AVLSA
TECX
Atlas Venture Life Science Advisors’s Tectonic Therapeutic, Inc. Common Stock TECX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-78,447
| Closed | -$3.62M | – | 14 |
|
|
2024
Q4 | $3.62M | Sell |
78,447
-300,000
| -79% | -$13.9M | 0.44% | 12 |
|
|
2024
Q3 | $11.5M | Hold |
378,447
| – | – | 1.06% | 10 |
|
|
2024
Q2 | $6.23M | Sell |
378,447
-4,162,934
| -92% | -$68.6M | 0.66% | 12 |
|
|
2024
Q1 | $5.81M | Hold |
4,541,381
| – | – | 0.54% | 13 |
|
|
2023
Q4 | $6.18M | Hold |
4,541,381
| – | – | 0.74% | 13 |
|
|
2023
Q3 | $6.99M | Hold |
4,541,381
| – | – | 1.08% | 12 |
|
|
2023
Q2 | $4.31M | Hold |
4,541,381
| – | – | 0.54% | 13 |
|
|
2023
Q1 | $4.54M | Buy |
4,541,381
+20,518
| +0.5% | +$20.5K | 0.61% | 13 |
|
|
2022
Q4 | $3.22M | Hold |
4,520,863
| – | – | 0.39% | 14 |
|
|
2022
Q3 | $2.91M | Hold |
4,520,863
| – | – | 0.32% | 15 |
|
|
2022
Q2 | $4.16M | Hold |
4,520,863
| – | – | 0.7% | 13 |
|
|
2022
Q1 | $5.97M | Hold |
4,520,863
| – | – | 0.75% | 14 |
|
|
2021
Q4 | $17.4M | Buy |
+4,520,863
| New | +$17.4M | 1.6% | 10 |
|